The Scientist

» industry and immunology

Most Recent

image: Stem Cells Off the Line

Stem Cells Off the Line

By | April 1, 2014

Researchers work to improve the efficiency of cell therapy manufacturing, while developing procedures to ensure consistent quality.      

0 Comments

image: Deploying the Body’s Army

Deploying the Body’s Army

By | April 1, 2014

Using patients’ own immune systems to fight cancer

3 Comments

image: Vitamin A’s Influence on Immunity

Vitamin A’s Influence on Immunity

By | March 19, 2014

Exposure to vitamin A in the womb influences immune system development and lifelong ability to fight infections, a mouse study shows. 

1 Comment

image: Incubator Boom

Incubator Boom

By | March 1, 2014

From San Francisco to St. Louis, biotech incubators are proliferating across North America. Can they deliver on their promise of fueling the economy?  

1 Comment

image: Antibody Maker Headed to Court

Antibody Maker Headed to Court

By | February 17, 2014

The USDA claims that Santa Cruz Biotechnology, one of the biggest suppliers of antibodies for laboratory research, repeatedly violated the Animal Welfare Act.

6 Comments

image: Biotech, Meet Crowdfunding

Biotech, Meet Crowdfunding

By | February 13, 2014

Proposed regulations from the US Securities and Exchange Commission have the biotech industry tuning in to the roar of the crowd.  

0 Comments

image: Week in Review: February 3–7

Week in Review: February 3–7

By | February 7, 2014

Federal stem cell regulations vary; Salmonella exploit host immune system; microglia help maintain synaptic connections; prosthesis re-creates feeling of touch

0 Comments

image: Immune Response Promotes Infection

Immune Response Promotes Infection

By | February 6, 2014

Salmonella enterica can exploit a standard immune response in mice to promote its own growth.

2 Comments

image: $230M for Big Disease

$230M for Big Disease

By | February 5, 2014

The National Institutes of Health is partnering with 10 drug companies to find new treatments for Alzheimer’s disease, diabetes, rheumatoid arthritis, and lupus.

1 Comment

image: New Year’s Biotech IPO Boom?

New Year’s Biotech IPO Boom?

By | February 3, 2014

January was a profitable month for biotech companies going public, Burrill & Company says.

5 Comments

Popular Now

  1. Largest Human Genetic Variation Repository Yet
  2. With CRISPR, Scientists Make Neurons From Fibroblasts
  3. The Neanderthal in the Mirror
    Reading Frames The Neanderthal in the Mirror

    Our evolutionary cousin is no longer a blundering caveman. Recent research has painted a picture of a human ancestor with culture, art, and advanced cognitive skills.

  4. Student Alleges His Team Didn’t Earn CRISPR Patent
RayBiotech